橘皮组织治疗市场-增长、趋势、COVID-19 影响和预测 (2023-2028)
市场调查报告书
商品编码
1190263

橘皮组织治疗市场-增长、趋势、COVID-19 影响和预测 (2023-2028)

Cellulite Treatment Market - Growth, Trends, and Forecasts (2023 - 2028)

出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

脂肪团治疗市场预计在未来五年内以 7.9% 的复合年增长率增长。

COVID-19 大流行对市场增长产生了强烈影响。 这主要是由于大流行期间脂肪团治疗程序的减少。 例如,根据美国整形外科学会 2020 年发布的数据,2020 年有 86,350 次脂肪团治疗程序,而 2019 年有 112,975 次脂肪团治疗程序。 在大流行期间,橘皮组织治疗程序下降了 24%,在大流行期间对市场产生了负面影响。 然而,大流行后严格的封锁限制的放鬆使得诊所和医院得以重新开放,增加了患者的涌入。 预计这将有助于未来几年的市场增长。

主要的市场增长因素是久坐不动的生活方式的增加、导致脂肪团形成的饮食失调以及肥胖人口的增加。 肥胖流行现在被认为是最重要的公共卫生问题之一。 根据 C3 机构 2021 年 7 月的新闻稿,肥胖已成为法国人的主要关注点,在过去 25 年中法国的肥胖率翻了一番。 此外,健康改善与差异办公室于 2022 年 7 月更新的数据显示,在 2020 年 11 月至 2021 年 11 月期间,英国 25.3% 的 18 岁及以上成年人将患有肥胖症。据说确实存在。 预计这种肥胖爆发将推动市场增长。

此外,橘皮组织治疗技术的创新推出、宣传活动和产品批准有望促进市场增长。 例如,2022 年 8 月,AirScult Technologies Inc. 推出了 AirSculpt Smooth,这是一种微创、单次治疗的脂肪团去除技术。 同样,2021 年 7 月,Endo International PLC 推出了“Really Cellulite”,旨在消除与脂肪团相关的错误信息。

生活习惯的增加最终将导致对橘皮组织治疗的需求增加。 此外,脂肪团的形成影响个体的心理、行为和心理特征。 因此,上述因素预计将在预测期内推动市场增长。

橘皮组织治疗市场趋势

刚性脂肪团细分市场预计将占据脂肪团治疗市场的主要市场份额

近年来,僵硬的橘皮组织占据了市场主导地位。 由于患者和医生的偏好,皮肤科诊所和医院的高需求预计将在预测期内主导市场。 推动脂肪团治疗增长的主要因素之一是肥胖人群的增加。 此外,脂肪沉积的病例也在增加。

根据 2021 年 3 月发表的 NCBI 文章,固体或硬脂肪团在年轻女孩中更为常见,通常出现在臀部和大腿上部周围。 该报告指出,中胚层疗法是最好的治疗方法之一,涉及将维生素、药物和天然成分的定制组合注入在表面下起作用的中胚层。我来了。 肥胖病例的增加已经引起人们对治疗脂肪团的整容手术的认识,扩大了市场上此类手术的范围。

预计在预测期内,不同治疗方式的可用性也将有助于该细分市场的增长。 例如,由 Macom 发布的数据指出,一些整容外科医生推荐使用 Selfina 等基于切除的治疗方法来治疗紧凑型脂肪团。 Biotypsa 还使用脂肪空化技术提供密集的脂肪团减少和建模结果,以减少硬脂肪团。

因此,各种先进治疗程序的可用性和硬脂肪团的流行预计将在预测期内促进该细分市场的增长。

北美在市场上占主导地位,预计在预测期内也会如此。

北美已成为橘皮组织治疗的主要市场,原因是久坐不动的生活方式导致肥胖症越来越普遍,并且该地区越来越多地采用先进技术。 近年来,已经从外科手术转向非侵入性治疗。 根据 Trust for Americas Health 于 2022 年 9 月发表的一篇文章,美国有 19 个州的肥胖率超过 35%。 预计美国的这种肥胖发生率将推动所研究市场的增长。

报告显示,每 10 个美国成年人中就有 4 个肥胖,而且全国范围内的肥胖率还在持续上升。 预计美国人口中肥胖症的增加将推动对橘皮组织治疗的需求。

美国疾病控制与预防中心2021年5月发表的一篇文章提到,2020年美国有3,664,292人登记出生。 出生率和怀孕的这种增加预计将推动对脂肪团治疗的需求,并有助于市场的增长。

美国产品批准数量的增加预计也将有助于所研究市场的增长。 例如,2021 年 2 月,美国食品和药物管理局批准了 Soliton Inc. 的快速声脉衝技术,以在短期内改善橘皮组织的外观。

因此,预计上述因素等因素将在预测期内推动市场增长。

脂肪团治疗市场竞争分析

脂肪团治疗市场竞争适中,由几家主要参与者组成。 就市场收入份额而言,一些主要参与者目前主导着市场。 一些着名的参与者正在推出新产品,而另一些则正在分销他们的产品。 市场垄断企业包括 Merz Pharma GmbH & Co. KGaA、Cutera Inc.、Hologic Inc.、Candela Corporation 和 Inceler Medikal。

其他好处

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 研究假设和市场定义
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 市场概览
  • 市场驱动力
    • 肥胖患者增加
    • 增加对手术的抵抗力
  • 市场製约因素
    • 新兴国家缺乏对脂肪团治疗的认识
    • 采用替代传统和草药按摩疗法
  • 波特的五力分析
    • 新进入者的威胁
    • 买方/消费者议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 竞争公司之间的敌对关係

第 5 章市场细分(基于价值的市场规模 - 百万美元)

  • 通过手术方法
    • 微创
    • 非侵入性
    • 局部治疗
  • 脂肪团
    • 柔软的橘皮组织
    • 硬脂肪团
    • 水肿橘皮组织
  • 最终用户
    • 医院
    • 整容手术
    • 皮肤科诊所
  • 按地区列出
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲地区
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区
    • 中东和非洲
      • 海湾合作委员会
      • 南非
      • 其他中东地区
    • 南美洲地区
      • 巴西
      • 阿根廷
      • 其他南美洲

第六章竞争格局

  • 公司简介
    • Merz Pharma GmbH & Co KGaA
    • Inceler Medikal Co. Ltd
    • Candela Corporation
    • Hologic Inc.
    • Cutera Inc.
    • Nestle SA
    • Tanceuticals LLC
    • Zimmer Aesthetics
    • cymedics GmbH & Co KG
    • Beijing Nubway S&T Co Ltd

第七章市场机会与未来趋势

简介目录
Product Code: 67795

The cellulite treatment market is anticipated to witness a CAGR of 7.9% during the next five years.

The COVID-19 pandemic had a strong impact on the growth of the market. This was mainly due to the reduction of cellulite treatment procedures during the pandemic. For instance, as per the data published by the American Society of Plastic Surgeons in 2020, cellulite treatment procedures in 2020 were 86,350 compared to 2019, which had 112,975 cellular treatment procedures. There was a 24% reduction in cellulite treatment procedures during the pandemic, impacting the market negatively during the pandemic. However, the relaxation of strict lockdown regulations in the post-pandemic period led to the reopening of clinics and hospitals and a rise in patient inflow. This is expected to contribute to the growth of the market in the coming years.

The major market growth factors are a rise in the sedentary lifestyle, poor dietary habits resulting in cellulite formation, and an increasing obesity population. The prevalence of obesity is now considered one of the most important public health problems. As per a press release in July 2021 by the C3 organization, obesity has become a major concern among the French population, and it has doubled in France over the last 25 years. Additionally, according to the Office for Health Improvement and Disparities data updated in July 2022, from November 2020 to November 2021, 25.3% of adults aged 18 and above were living with obesity in England. Such an incidence of obesity is expected to drive the growth of the market.

Moreover, innovative launches, awareness campaigns, and product approvals of cellulite treatment technologies are expected to contribute to the growth of the market. For instance, in August 2022, AirScult Technologies Inc. launched AirSculpt Smooth, a cellulite removal technology that is a minimally-invasive one-time procedure. Similarly, in July 2021, Endo International PLC launched "Really Cellulite", designed to eliminate the misinformation relating to cellulite.

The rising lifestyle-related habits would ultimately lead to an increase in demand for cellulite treatment. Furthermore, the formation of cellulite affects an individual's psychological, behavioral, and psychiatric characteristics. Hence, the above-mentioned factors are expected to drive the growth of the market during the forecast period.

Cellulite Treatment Market Trends

Hard Cellulite Segment is Expected to Hold the Major Market Share in the Cellulite Treatment Market

The hard cellulite segment dominated the market in recent years. It is expected to dominate the market during the forecast period due to high demand from specialized dermatology clinics and hospitals, owing to the preference of the patients and physicians. One of the major drivers for the growth of cellulite treatment is the increasing number of obese people. There is also an increased number of cases of fat deposition.

According to an NCBI article published in March 2021, solid or hard cellulite is quite common in younger girls and is usually found around the hips and upper thighs. The report also mentioned that mesotherapy is one of the best treatments, which includes injecting customized combinations of vitamins, drugs, and natural takeouts into the mesoderm layer, which works under the surface. The increasing number of obesity cases created awareness among people regarding cosmetic procedures for the treatment of cellulite and broadened the scope of such surgeries in the market.

Also, the availability of various treatment procedures is expected to contribute to the growth of the segment over the forecast period. For instance, the data published by Macom mentioned that some cosmetic surgeons recommend excision-based treatments, such as Cellfina, to treat compact cellulite. Also, the company, Biotypsa uses Fat Cavitation technology, which offers intensive fatty cellulite reduction and modeling results for reducing hard cellulite.

Thus, the availability of various advanced treatment procedures and the prevalence of hard cellulite are expected to contribute to the growth of the segment over the forecast period.

North America Dominates the Market and is Expected to Do the Same During the Forecast Period.

North America is the primary market for cellulite treatment, owing to the rise in the number of obesity cases due to a sedentary lifestyle and an increase in the adoption of advanced technologies in the region. A shift from surgical procedures toward non-invasive treatments has increased in recent years. As per the article published by the Trust for America's Health in September 2022, 19 states in United States have obesity rates over 35%. Such an incidence of obesity in United States is expected to drive the growth of the market studied.

According to the same report, four in ten American adults have obesity, and obesity rates continue to increase nationwide. Such an increase in obesity among the US population is expected to drive the demand for cellulite treatment.

An article published by the Centers for Disease Control and Prevention in May 2021 mentioned that the registered number of births in United States in 2020 was 3,664,292. Such an increase in birth rates and pregnancy is expected to drive the demand for cellulite treatment, thereby contributing to the growth of the market.

Also, the increasing product approvals in United States are expected to contribute to the growth of the market studied. For instance, in February 2021, United States Food and Drug Administration approved the Rapid Acoustic pulse technology by Soliton Inc. for short-term improvement in the appearance of cellulite.

Thus, the above-mentioned factors are expected to drive the growth of the market during the forecast period.

Cellulite Treatment Market Competitive Analysis

The cellulite treatment market is moderately competitive and consists of several major players. In terms of market revenue share, a few key players are currently dominating the market. Some prominent players are launching new products, while others are distributing the products. Some of the companies dominating the market are Merz Pharma GmbH & Co. KGaA, Cutera Inc., Hologic Inc., Candela Corporation, and Inceler Medikal Co. Ltd.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 The Rise in Prevalence of Obesity Cases
    • 4.2.2 Increased Reluctance Toward Surgical Procedures
  • 4.3 Market Restraints
    • 4.3.1 Lack of Awareness about Cellulite Treatment in Emerging Countries
    • 4.3.2 Adoption of Substituent Traditional and Herbal Massage Therapies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD million)

  • 5.1 By Procedure
    • 5.1.1 Minimally Invasive
    • 5.1.2 Non-invasive
    • 5.1.3 Topical
  • 5.2 By Cellulite
    • 5.2.1 Soft Cellulite
    • 5.2.2 Hard Cellulite
    • 5.2.3 Edematous Cellulite
  • 5.3 By End User
    • 5.3.1 Hospitals
    • 5.3.2 Cosmetic Surgery Centers
    • 5.3.3 Specialized Dermatology Clinics
  • 5.4 By Geography
    • 5.4.1 North America
      • 5.4.1.1 United States
      • 5.4.1.2 Canada
      • 5.4.1.3 Mexico
    • 5.4.2 Europe
      • 5.4.2.1 Germany
      • 5.4.2.2 United Kingdom
      • 5.4.2.3 France
      • 5.4.2.4 Italy
      • 5.4.2.5 Spain
      • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
      • 5.4.3.1 China
      • 5.4.3.2 Japan
      • 5.4.3.3 India
      • 5.4.3.4 Australia
      • 5.4.3.5 South Korea
      • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
      • 5.4.4.1 GCC
      • 5.4.4.2 South Africa
      • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
      • 5.4.5.1 Brazil
      • 5.4.5.2 Argentina
      • 5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Merz Pharma GmbH & Co KGaA
    • 6.1.2 Inceler Medikal Co. Ltd
    • 6.1.3 Candela Corporation
    • 6.1.4 Hologic Inc.
    • 6.1.5 Cutera Inc.
    • 6.1.6 Nestle SA
    • 6.1.7 Tanceuticals LLC
    • 6.1.8 Zimmer Aesthetics
    • 6.1.9 cymedics GmbH & Co KG
    • 6.1.10 Beijing Nubway S&T Co Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS